WASHINGTON, DC — A new consensus statement released this week by the Heart Rhythm Society (HRS) and nine other medical societies provides physicians practical clinical advice on cardiac implantable ...

New evidence on cardiovascular implantable electronic devices (CIED) lead management and the burgeoning development of new CIED technologies have contributed to the ...

COLORADO SPRINGS, Colo., The Spectranetics Corporation today announced U.S. Food and Drug Administration (FDA) Premarket Notification 510(k) submission of the Bridge Occlusion Balloon. Building on the ...

Less than one out of every eight patients with infective endocarditis and a cardiac implantable electronic device (CIED) underwent recommended transvenous lead removal/extraction over a recent 4-year ...